# TaVNS for Acute Intracerebral Hemorrhage

Study · id `cardio:ct-nct06918964` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06918964](<https://clinicaltrials.gov/study/NCT06918964>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06918964

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 186 participants.

## Technical summary

Registry record NCT06918964. Randomized; double masking; primary purpose treatment. Start 2025-09-15 (actual); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 186 participants (planned count; ClinicalTrials.gov record NCT06918964, source copy `cardio:ctgov-nct06918964-2026-01-15`, retrieved 2026-10-31)
- Started: 2025-09-15 (actual) (ClinicalTrials.gov record NCT06918964, source copy `cardio:ctgov-nct06918964-2026-01-15`, retrieved 2026-10-31)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT06918964, source copy `cardio:ctgov-nct06918964-2026-01-15`, retrieved 2026-10-31)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT06918964, source copy `cardio:ctgov-nct06918964-2026-01-15`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06918964, source copy `cardio:ctgov-nct06918964-2026-01-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06918964-2026-01-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: TaVNS for Acute Intracerebral Hemorrhage
- Acronym: TAVANS-ICH
- Condition: Intracerebral Hemorrhage
- Intervention (Device): transcutaneous auricular vagus nerve stimulation device
- Intervention (Device): Sham device
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: b6d0c5a7f13cf59ad02fff60c4b43060636983c213eaa528cdd524bef3a2b123
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
